Medios AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8.40
20.80
1,206.00
17,091.00
16,685.30
11,771.90
Total Accounts Receivable
211.40
43.30
1,755.00
15,635.00
18,792.10
34,876.70
Inventories
-
-
1,713.00
6,755.00
10,676.20
14,256.30
Other Current Assets
14.50
25.60
-
-
-
155.60
Total Current Assets
234.30
89.80
4,674.00
39,481.00
46,153.60
61,060.60
Net Property, Plant & Equipment
0.00
-
116.00
618.00
5,442.00
5,641.30
Intangible Assets
0.00
0.00
10.00
7,326.00
9,254.80
31,615
Total Assets
234.30
89.80
4,800.00
47,861.00
61,706.60
98,416.80
Accounts Payable
81.30
17.90
2,862.00
9,851.00
11,881.50
Income Tax Payable
-
-
321.00
1,938.00
997.90
Other Current Liabilities
77.10
2.70
295.00
1,808.00
2,772.60
Total Current Liabilities
158.40
20.60
3,478.00
13,597.00
15,652.00
Provision for Risks & Charges
68.20
69.20
-
-
-
Deferred Taxes
-
-
-
271.00
478.20
Total Liabilities
226.50
89.80
3,478.00
13,762.00
16,030.00
Common Equity (Total)
7.80
-
1,322.00
32,119.00
45,676.50
Total Shareholders' Equity
7.80
-
1,322.00
32,119.00
45,676.50
Total Equity
7.80
-
1,322.00
34,099.00
45,676.50
Liabilities & Shareholders' Equity
234.30
89.80
4,800.00
47,861.00
61,706.60
Accumulated Minority Interest
-
-
-
1,980.00
-

About Medios

View Profile
Address
Friedrichstrasse 113a
Berlin Berlin 10117
Germany
Employees -
Website http://www.medios.ag
Updated 07/08/2019
Medios AG engages in providing specialty pharmaceutical drugs. These are medicines for patients with rare or chronic diseases such as cancer, HIV and hepatitis, whose personalized therapy is often tedious and cost-intensive due to their individual requirements. It operates through the following segments: Specialty Pharma Trade, Personalized Preparations, and Shared Services.